Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,867 INR | -0.32% | +3.54% | -6.27% |
04-16 | Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak | CI |
03-28 | Alkem Laboratories Forms Subsidiary for Medical Devices Business | MT |
Sales 2024 * | 129B 1.55B 2.12B | Sales 2025 * | 142B 1.7B 2.33B | Capitalization | 584B 7B 9.59B |
---|---|---|---|---|---|
Net income 2024 * | 18.67B 224M 307M | Net income 2025 * | 21.7B 260M 356M | EV / Sales 2024 * | 4.37 x |
Net cash position 2024 * | 20.12B 241M 330M | Net cash position 2025 * | 27.86B 334M 457M | EV / Sales 2025 * | 3.91 x |
P/E ratio 2024 * |
31.9
x | P/E ratio 2025 * |
27.1
x | Employees | 16,871 |
Yield 2024 * |
0.89% | Yield 2025 * |
1% | Free-Float | 36.2% |
Latest transcript on Alkem Laboratories Limited
1 day | -0.32% | ||
1 week | +3.54% | ||
Current month | -1.48% | ||
1 month | -2.75% | ||
3 months | -1.66% | ||
6 months | +31.87% | ||
Current year | -6.27% |
Managers | Title | Age | Since |
---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 23-09-21 |
Nitin Agrawal
DFI | Director of Finance/CFO | - | 01-31 |
Manish Narang
CMP | Compliance Officer | 54 | 06-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 84 | 73-08-07 | |
Sandeep Singh
BRD | Director/Board Member | 41 | 13-08-08 |
Director/Board Member | 61 | 87-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 4,867 | -0.32% | 521 |
24-04-29 | 4,883 | -0.38% | 3,778 |
24-04-26 | 4,902 | +0.62% | 139,669 |
24-04-25 | 4,871 | +3.39% | 1,969 |
24-04-24 | 4,712 | +0.24% | 677 |
Delayed Quote Bombay S.E., April 30, 2024 at 04:10 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.47% | 664B | |
+25.70% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.42% | 234B | |
+4.71% | 199B | |
-10.10% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- ALKEM Stock
- ALKEM Stock